MedPath

A clinical trial to study the role of fractional excretion of urea in chronic liver disease patients with acute kidney failure.

Not Applicable
Conditions
Health Condition 1: K74- Fibrosis and cirrhosis of liver
Registration Number
CTRI/2023/02/049763
Lead Sponsor
GB Pant Institute of Post graduate Medical education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed cases of cirrhosis having ascites with AKI Stage IB with Serum creatinine more than or equal to 1.5mg/dl

Exclusion Criteria

1) Advanced Chronic Kidney Disease (serum creatinine >4mg/dl)

2) Prior Kidney or Liver Transplant

3) Acute or chronic Renal Replacement Therapy at the time of enrolment

4) Confirmed pregnancy

5) Diagnosed case of Hepatocellular carcinoma

6) Extrahepatic Malignancy

7) Severe Co-morbidities (CHF, COPD)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity, Specificity, Positive predictive value, Negative predictive value of FEUrea in decompensated cirrhotic patients with Acute Kidney injury for differentiating ATN-AKI vs Non-ATN-AKI.Timepoint: DAY 0 AND DAY 3
Secondary Outcome Measures
NameTimeMethod
Sensitivity, specificity, Positive predictive value, Negative predictive value of FEUrea in <br/ ><br>decompensated cirrhotic patients with Acute Kidney injury for differentiating HRS-AKI vs <br/ ><br>Non-HRS-AKI. <br/ ><br>Sensitivity, specificity, Positive predictive value, Negative predictive value of FEUrea in <br/ ><br>decompensated cirrhotic patients with Acute Kidney injury for differentiating PRA-AKI vs <br/ ><br>Non-PRA-AKI.Timepoint: DAY 0 AND DAY 3
© Copyright 2025. All Rights Reserved by MedPath